Life Sciences Tools and Services
Company Overview of MPI Research, Inc.
MPI Research, Inc. provides preclinical and early clinical contract research services for biopharmaceutical, medical device, animal health, and chemical industries. The company supports drug safety, discovery sciences, surgical and medical device evaluation, and bioanalytical and analytical solutions in various therapeutic areas. It offers discovery services in metabolic, cardiovascular, orthopaedic, renal, neurosciences, inflammation, infectious disease, oncology, stem cell therapeutics, ophthalmology, and orthopedic areas, including joint/cartilage, bone fracture/defect repair, and spinal fusion and spinal instability/fixation models, as well as in other therapeutic areas, such as safety p...
54943 North Main Street
Mattawan, MI 49071
Founded in 1995
Key Executives for MPI Research, Inc.
Chairman, Chief Executive Officer and President
Chief Financial Officer and Executive Vice President
Chief Compliance Officer, Vice President and Institutional Animal Care & Use Committee Chair
Senior Vice President of Drug Safety & Discovery and Senior Principal Study Director
Compensation as of Fiscal Year 2015.
MPI Research, Inc. Key Developments
MPI Research, Inc. Presents at Washington Biotechnology & Biomedical Association 14th Annual Life Science Innovation Northwest 2014, Jun-19-2014 03:50 PM
Jun 11 14
MPI Research, Inc. Presents at Washington Biotechnology & Biomedical Association 14th Annual Life Science Innovation Northwest 2014, Jun-19-2014 03:50 PM. Venue: Washington State Convention Center, Seattle, Washington, United States.
MPI Research, inviCRO, and 3D Imaging Announce New Translational Imaging Center to Speed Drug Development, Lower Costs
Feb 4 14
MPI Research, inviCRO, and 3D Imaging formally announced the name of their new advanced imaging center being built at the MPI Research headquarters in Mattawan, Mich. A joint partnership by the three organizations, the Translational Imaging Center, is the first resource for the drug development community to combine molecular imaging, autoradiography, and animal modeling with an onsite cyclotron, vivarium, and advanced image analytics. When completed in early spring, the Center will have the unique ability to efficiently translate preclinical data to clinical data, yielding critical insights capable of accelerating decisions, discoveries and innovation. As a result, drug developers will have access to imaging, radiochemistry, and informatics solutions to position their teams to make faster, better informed decisions regarding a drug candidate's potential. The 10,000-square-foot, two-story Translational Imaging Center will leverage the distinct and complementary strengths of each partner, including inviCRO's molecular imaging informatics team, 3D Imaging's radiopharmaceutical group, and the comprehensive CRO-based services of MPI Research.
MPI Research Names D. Thomas Tom Oakley as President and Chief Operating Officer
Oct 14 13
MPI Research announced that D. Thomas Tom Oakley has been appointed as President and Chief Operating Officer. Tom recently joined the company as Executive Vice President of Preclinical Operations. Oakley is an eminent senior executive with over 30 years of domestic and international strategic and operational leadership experience in major contract research organizations, industrial and consumer product businesses, and the United States Army. He most recently was President and CEO of ChanTest Corporation. Prior to ChanTest, Oakley was the President and CEO of Bridge Laboratories.
Similar Private Companies By Industry
Recent Private Companies Transactions